Patents by Inventor Eldridge Myles Glenn

Eldridge Myles Glenn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of use of pyridylalkyl phenylthioureas
    Patent number: 4112100
    Abstract: A method of improving the endogenous production of prostaglandins by a mammal is disclosed which comprises administering to the mammal an effective amount of certain 1-pyridylalkyl-3-phenylthioureas. Disclosed also are novel substituted 1-pyridylalkyl-3-phenylthioureas and therapeutic compositions thereof which are useful in carrying out the method of the invention.Disclosed also are methods of treating mammals for clinical conditions responsive to prostaglandins, such as for example, male infertility, epidermal injuries, atonic uterine bleeding, thromboembolic disease and like clinical conditions.
    Type: Grant
    Filed: June 25, 1975
    Date of Patent: September 5, 1978
    Assignee: The Upjohn Company
    Inventors: William A. Callahan, Eldridge Myles Glenn, Douglas L. Rector
  • Novel benzamides
    Patent number: 4069224
    Abstract: A method of improving the endogenous production of prostaglandins by a mammal is disclosed, which comprises administering to the mammal an effective amount of an N-(pyridylalkyl)benzamides. Disclosed also are novel N-(pyridylalkyl)benzamides and therapeutic compositions thereof which are useful in carrying out the method of the invention.Disclosed also are methods of treating mammals for clinical conditions responsive to prostaglandins, such as for example, male infertility, epidermal injuries, atonic uterine bleeding, thromboembolic disease and like clinical conditions.
    Type: Grant
    Filed: June 25, 1975
    Date of Patent: January 17, 1978
    Assignee: The Upjohn Company
    Inventors: William A. Callahan, Eldridge Myles Glenn, Douglas L. Rector
  • Substituted ureas and thioureas and pharmaceutical compositions thereof
    Patent number: 4008326
    Abstract: A method of improving the endogenous production of prostaglandins by a mammal is disclosed, which comprises administering to the mammal an effective amount of 1-pyridylalkyl-3-naphthyl-2(thio)ureas. Disclosed also are novel substituted 1-pyridylalkyl-3-naphthyl-2(thio)ureas and therapeutic compositions thereof which are useful in carrying out the method of the invention.Disclosed also are methods of treating mammals for clinical conditions responsive to prostaglandins, such as, for example, male infertility, epidermal injuries, atonic uterine bleeding, thromboembolic disease and like clinical conditions.
    Type: Grant
    Filed: June 25, 1975
    Date of Patent: February 15, 1977
    Assignee: The Upjohn Company
    Inventors: William A. Callahan, Eldridge Myles Glenn, Douglas L. Rector
  • Pyridylalkyl phenyl ureas and their N-oxides
    Patent number: 4001256
    Abstract: A method of improving the endogenous production of prostaglandins by a mammal is disclosed, which comprises administering to the mammal an effective amount of certain 1-pyridylalkyl-3-phenylureas. Disclosed also are novel substituted 1-pyridylalkyl-3-phenylureas and therapeutic compositions thereof which are useful in carrying out the method of the invention.Disclosed also are methods of treating mammals for clinical conditions responsive to prostaglandins, such as, for example, male infertility, epidermal injuries, atonic uterine bleeding, thromboembolic disease and like clinical conditions.
    Type: Grant
    Filed: June 25, 1975
    Date of Patent: January 4, 1977
    Assignee: The Upjohn Company
    Inventors: William A. Callahan, Eldridge Myles Glenn, Douglas L. Rector